North American Indapamide Market is estimated to grow significantly at a CAGR of around 0.3% during the forecast period. The market is mainly growing due to the rising prevalence of hypertension and CVD such as heart strokes, blood pressure, arrhythmias among others. According to the Heart & Stroke Foundation in Canada (2017), 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease. Further, the population is also more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are the highest in North America, which is responsible for 700,000 fatalities each year. Moreover, the rate of adoption of advanced techniques is the highest in North America which in turn supports the growth of the market in North America.
Get Free Sample link @ https://www.omrglobal.com/request-sample/north-american-indapamide-market
TheNorth American Indapamide Market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.
A full report ofNorth American Indapamide Market available @ https://www.omrglobal.com/industry-reports/north-american-indapamide-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
North American Indapamide Market by Product
- 25 MG
- 5 MG
North American Indapamide Market by Application
- High Blood Pressure
- Heart Failure
- Others
Regional Analysis
- US
- Canada
Company Profiles
- ANI Pharmaceuticals, Inc.
- Apotex Inc.
- Glenmark Pharmaceuticals Ltd.
- Krka Group
- Mylan N.V.
- Preferred Pharmaceuticals, Inc.
- Sanis Health Inc.
- Sanofi S.A.
- Teva Pharmaceuticals Industries Ltd.
- Servier Group
The Report Covers
- Comprehensive research methodology of the North American indapamide market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American indapamide market.
- Insights about market determinants which are stimulating the North American indapamide market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-indapamide-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
